Surrogate virus neutralisation test (sVNT) for detection of the inhibitory effect of neutralising antibodies directed against the receptor binding domain (RBD) of the S1 protein of SARS-CoV-2
Supports the analysis of the immune response after SARS-CoV-2 infection or vaccination
100 % agreement of results compared with a plaque reduction neutralisation test (PRNT50)
Established ELISA method – suitable for routine laboratory diagnostics, no BSL-3 laboratory required
Automatable even for high-throughput analysis, results available in 2 hours
Modelled upon nature: Neutralising antibodies in the sample compete with the host-cell receptor (ACE2) for the binding to S1/RBD in the first incubation step, no preadsorption required
Nous contacter
27, rue Abou Hamed Al Ghazali, Boulevard Rachidi, Casablanca, Maroc
